Total Tracked 10,000 clinical trials
Recruiting Now 500 100% of sample
Active Studies 500 enrolling or running
Completed 0 in this dataset
Avg Enrollment 3,525 participants per trial
Whole Registry 604,566 studies on ClinicalTrials.gov, 28 September 2026

By Trial Status

Recruiting
500
By Trial Phase
EARLY_Phase 1
5
Phase 1
20
Phase 1, Phase 2
27
Phase 2
57
Phase 2, Phase 3
7
Phase 3
24
Phase 4
23
N/A
337
By Study Type
INTERVENTIONAL 375 75%
OBSERVATIONAL 125 25%
By Sex Eligibility
ALL 434 87%
FEMALE 53 11%
MALE 13 3%
Top Sponsors by Trial Count
Assistance Publique - Hôpitaux de Paris
5
Stanford University
5
Sun Yat-sen University
5
M.D. Anderson Cancer Center
4
Oslo University Hospital
4
Abramson Cancer Center at Penn Medicine
4
Peking Union Medical College Hospital
4
Hospices Civils de Lyon
4
Ruijin Hospital
4
University of California, San Diego
4

Zooming out: the entire registry

Everything above comes from ClinicalMetric's own daily feed. This part doesn't. On 28 September 2026 we counted all 604,566 studies on ClinicalTrials.gov, every status, every year, so you can see where the recruiting slice sits inside the whole thing.

Completed
330,329 54.6%
Unknown status
96,838 16.0%
Recruiting
65,044 10.8%
Terminated
34,380 5.7%
Not yet recruiting
29,938 5.0%
Active, not recruiting
22,134 3.7%
Withdrawn
16,812 2.8%
Enrolling by invitation
5,263 0.9%
Suspended
1,777 0.3%
Only about one study in nine is open.
65,044 are recruiting right now, which is 10.8% of the registry. Add the 29,938 that say they'll open soon and the 5,263 enrolling by invitation, and you're still at about one in six.
"Unknown status" is the second-biggest group, and it's not a small footnote.
ClinicalTrials.gov puts a study here when its record still says it is ongoing, its expected completion date has passed, and nobody has verified the record in more than two years. 96,838 studies, 16.0% of everything registered, have gone quiet like this. If you find an interesting study with this label, contact the site before you get your hopes up.
Stopped studies add up.
Terminated (34,380), withdrawn (16,812) and suspended (1,777) together come to 52,969 studies. We looked at why they stop in our analysis of terminated and withdrawn trials. Short version: running out of participants beats every scientific reason combined.

Who leads the 65,044 recruiting studies

Universities, hospitals & other non-profits51,278 78.8%
Industry10,375 16.0%
Other government bodies1,649 2.5%
NIH819 1.3%
Research networks495 0.8%
Other US federal agencies419 0.6%

Industry leads roughly one recruiting study in six. The large "non-profit" group is mostly universities and hospitals, and it includes every observational and behavioural study they run, so it isn't a measure of funding.

Where they're recruiting (at least one site)

United States22,060
China11,701
France6,025
Italy4,109
Canada3,513
Spain3,103
Germany2,882
United Kingdom2,824
Turkey2,491
Netherlands1,831

A study with sites in five countries counts once in each. France and Italy both rank above Germany and the UK.

Of the recruiting studies, 47,506 are interventional (they test something) and 17,538 are observational (they watch and measure). 12,806 accept healthy volunteers. Source: ClinicalTrials.gov API v2, 28 September 2026. These figures are a fixed snapshot and won't move with the daily feed above.

Data sourced from ClinicalTrials.gov (NIH). Statistics reflect the most recent daily cache of 500 trials. Total registry count: 10,000 tracked studies. For medical decisions, always consult a qualified healthcare provider.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology